DB
PRCT icon

Dmitry Balyasny’s Procept Biorobotics PRCT Stock Holding History

Dmitry Balyasny’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$637K Sell
28,201
-45,741
-62% -$1.15M ﹤0.01% 2421
2026
Q1 		$1.85M Buy
+73,942
New +$2.08M ﹤0.01% 1815
2024
Q1 		– Sell
-37,797
Closed -$1.58M – 3011
2023
Q4 		$1.58M Buy
37,797
+11,060
+41% +$377K ﹤0.01% 1521
2023
Q3 		$877K Buy
+26,737
New +$912K ﹤0.01% 1597
2021
Q4 		– Sell
-29,355
Closed -$1.12M – 2524
2021
Q3 		$1.12M Buy
+29,355
New +$1.13M ﹤0.01% 1301

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dmitry Balyasny's PRCT Position: Q2 2026 in Review

Dmitry Balyasny reduced its Procept Biorobotics (PRCT) stake by 62% in Q2 2026, selling an estimated $1.15M and leaving 28,201 shares worth $637K. The position accounts for ﹤0.01% of the portfolio, ranked #2421.

Dmitry Balyasny first reported a position in PRCT in Q3 2021 and has held it in 5 quarters since. The position peaked at $1.85M in Q1 2026. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Dmitry Balyasny held 28,201 shares of Procept Biorobotics worth $637K as of Q2 2026.
  • Dmitry Balyasny sold 45,741 Procept Biorobotics shares in Q2 2026, an estimated $1.15M.
  • Procept Biorobotics made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2421 holding.
  • Dmitry Balyasny first reported a position in Procept Biorobotics in Q3 2021 and has held it in 5 quarters since.
  • Dmitry Balyasny's Procept Biorobotics position peaked at $1.85M in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.